LG Life Sciences Ltd. Pfd. Series 1 | Cash Flow
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
1,601,296
1,159,861
1,549,643
1,659,828
2,563,895
Depreciation, Depletion & Amortization
1,045,233
1,150,224
1,256,082
1,336,693
1,402,042
Other Funds
-
-
-
-
17,627
Funds from Operations
2,469,750
2,161,116
2,963,679
2,898,753
3,895,554
Changes in Working Capital
287,377
164,485
207,902
380,648
712,692
Net Operating Cash Flow
2,182,373
1,996,631
3,171,581
2,518,105
3,182,862
Capital Expenditures
1,401,995
1,461,380
1,707,021
1,472,614
2,350,594
Sale of Fixed Assets & Businesses
8,099
26,276
167,375
30,491
446,420
Purchase/Sale of Investments
25,494
42,049
10,011
2,770
31,378
Net Investing Cash Flow
1,310,258
1,975,104
1,694,093
1,723,830
1,640,356
Cash Dividends Paid - Total
308,405
299,850
309,412
346,485
368,055
Issuance/Reduction of Debt, Net
109,603
153,421
451,746
673,765
348,605
Net Financing Cash Flow
198,802
453,271
761,158
1,020,250
736,537
Net Change in Cash
677,776
408,832
716,353
229,143
777,088
Free Cash Flow
821,700
585,363
1,538,171
1,119,602
930,246
Net Assets from Acquisitions
-
136,418
-
537,276
-
Other Sources
1,253,748
982,008
1,044,777
960,793
1,133,419
Change in Capital Stock
-
-
-
-
2,250
Exchange Rate Effect
4,463
22,912
23
3,168
28,881
Other Uses
1,144,616
1,343,541
1,189,213
707,994
838,223
About LG Life Sciences
View Profile
